Role of Liquid Chlorophyll as Adjuvant Therapy in The Treatment of Iron Deficiency Anemia in Children

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202404598891273

Enrollment

Registered

2024-04-26

Start date

2024-05-15

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haematological Disorders Paediatrics

Interventions

Iron polymaltose complex

Iron polymaltose complex plus liquid chlorophyll

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children with iron deficiency anemia aged 1 -18 years.

Exclusion criteria

Exclusion criteria: 1. Children with iron deficiency anemia who are not compliant with liquid chlorophyll therapy. 2. Children with iron deficiency anemia who are allergic to liquid chlorophyll. 3. Children with contraindication of oral iron therapy as: a. Acute infection. b. Gastric disease that may be exaggerated by oral iron therapy e.g gastritis , gastric ulcer.

Design outcomes

Primary

Measure	Time frame
CBC parameters, serum iron profile and improvement of clinical manifestations of iron deficiency anemia.	—

Secondary

Measure	Time frame
Drug side effects	—

Countries

Egypt

Contacts

Public ContactDalia Ayoub

Lecturer of pediatrics

dalia.ayoub@med.tanta.edu.eg01066343989

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026